Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection.
Purity:
>99.0%
CAS Number:
[2429913-18-6]
* VAT and and shipping costs not included. Errors and price changes excepted